Request for Information on Conditions Relating to Cancer to Consider for the World Trade Center Health Program, 12740 [2011-5157]
Download as PDF
12740
Federal Register / Vol. 76, No. 45 / Tuesday, March 8, 2011 / Notices
response for the Annual Report). The
total estimated annualized reduction in
burden is 1,200 hours. There are no
costs to respondents other than their
time.
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Number of
respondents
Average
burden per
response
(in hrs.)
Total burden
(in hours)
Respondents
Form name
Block Grant Awardees ......................
Work Plan .........................................
Annual Report ..................................
61
61
1
1
20
15
1,220
915
Total ...........................................
...........................................................
........................
........................
122
2,135
Carol Walker,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–5170 Filed 3–7–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket Number NIOSH–227]
Request for Information on Conditions
Relating to Cancer to Consider for the
World Trade Center Health Program
National Institute for
Occupational Safety and Health
(NIOSH) of the Centers for Disease
Control and Prevention (CDC),
Department of Health and Human
Services (HHS).
ACTION: Notice and request for public
comments.
AGENCY:
srobinson on DSKHWCL6B1PROD with NOTICES
Comments must be received by
March 31, 2011.
DATES:
VerDate Mar<15>2010
19:12 Mar 07, 2011
Jkt 223001
You may submit comments,
identified by docket number NIOSH–
227, by any of the following methods:
• Mail: NIOSH Docket Office, Robert
A. Taft Laboratories, MS–C34, 4676
Columbia Parkway, Cincinnati, OH
45226.
• Facsimile: (513) 533–8285.
• E-mail: nioshdocket@cdc.gov.
All information received in response
to this notice will be available for public
examination and copying at the NIOSH
Docket Office, 4676 Columbia Parkway,
Cincinnati, Ohio 45226. The comment
period for NIOSH–227 will close on
March 31, 2011. All comments received
will be available on the NIOSH Docket
Web page at https://www.cdc.gov/niosh/
docket by April 30, and comments will
be available in writing by request.
NIOSH includes all comments received
without change in the docket and the
electronic docket, including any
personal information provided.
ADDRESSES:
The Director of the National
Institute for Occupational Safety and
Health (NIOSH) of the Centers for
Disease Control and Prevention (CDC)
serves as the World Trade Center (WTC)
Program Administrator for certain
functions related to the WTC Health
Program established by the James
Zadroga 9/11 Health and Compensation
Act (Pub. L. 111–347). In accordance
with Section 3312(a)(5)(A) of that Act,
the WTC Program Administrator is
conducting a review of all available
scientific and medical evidence to
determine if, based on the scientific
evidence, cancer or a certain type of
cancer should be added to the
applicable list of health conditions
covered by the World Trade Center
Health Program.
The WTC Program Administrator is
requesting information on the following:
(1) Relevant reports, publications, and
case information of scientific and
medical findings where exposure to
SUMMARY:
airborne toxins, any other hazard, or any
other adverse condition resulting from
the September 11, 2001 terrorist attacks,
is substantially likely to be a significant
factor in aggravating, contributing to, or
causing cancer or a type of cancer; (2)
clinical findings from the Clinical
Centers of Excellence providing
monitoring and treatment services to
WTC responders (i.e., those persons
who performed rescue, recovery, cleanup and remediation work on the WTC
disaster sites) and community members
directly exposed to the dust cloud on 9/
11/01; and (3) input on the scientific
criteria to be used by experts to evaluate
the weight of the medical and scientific
evidence regarding such potential
health conditions.
Dori
Reissman, M.D., NIOSH, Patriots Plaza
Suite 9200, 395 E St., SW., Washington,
FOR FURTHER INFORMATION CONTACT:
PO 00000
Frm 00050
Fmt 4703
Sfmt 4703
DC 20201, telephone (202) 245–0625 or
e-mail nioshdocket@cdc.gov.
John Howard,
Director, National Institute for Occupational
Safety and Health, Centers for Disease Control
and Prevention.
[FR Doc. 2011–5157 Filed 3–7–11; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–9978–N3]
Public Meeting of the Consumer
Operated and Oriented Plan (CO–OP)
Advisory Board; Meeting Location
Change
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting location
change.
AGENCY:
This notice announces the
change of location of the March 14,
2011, public meeting of the Consumer
Operated and Oriented Plan (CO–OP)
Advisory Board that was published in
the March 2, 2011 Federal Register (76
FR 1184 through 1185). In accordance
with the Federal Advisory Committee
Act, the meeting is open to the public.
DATES: March 14, 2011, from 8:30 a.m.
to 5 p.m., Eastern Standard Time (EST).
ADDRESSES: Meeting Location: Fairmont
Hotel, 2401 M Street, Washington, DC
20037.
FOR FURTHER INFORMATION CONTACT:
Anne Bollinger, (301) 492–4395. Press
inquiries are handled through CCIIO’s
Press Office at (202) 690–6343.
SUPPLEMENTARY INFORMATION: On March
2, 2011, we published a notice in the
Federal Register (76 FR 1184) that
announced a March 14, 2011, public
meeting for interested parties to assist
and advise the Secretary and the
Congress on the strategy of the
SUMMARY:
E:\FR\FM\08MRN1.SGM
08MRN1
Agencies
[Federal Register Volume 76, Number 45 (Tuesday, March 8, 2011)]
[Notices]
[Page 12740]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-5157]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket Number NIOSH-227]
Request for Information on Conditions Relating to Cancer to
Consider for the World Trade Center Health Program
AGENCY: National Institute for Occupational Safety and Health (NIOSH)
of the Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice and request for public comments.
-----------------------------------------------------------------------
SUMMARY: The Director of the National Institute for Occupational Safety
and Health (NIOSH) of the Centers for Disease Control and Prevention
(CDC) serves as the World Trade Center (WTC) Program Administrator for
certain functions related to the WTC Health Program established by the
James Zadroga 9/11 Health and Compensation Act (Pub. L. 111-347). In
accordance with Section 3312(a)(5)(A) of that Act, the WTC Program
Administrator is conducting a review of all available scientific and
medical evidence to determine if, based on the scientific evidence,
cancer or a certain type of cancer should be added to the applicable
list of health conditions covered by the World Trade Center Health
Program.
The WTC Program Administrator is requesting information on the
following: (1) Relevant reports, publications, and case information of
scientific and medical findings where exposure to airborne toxins, any
other hazard, or any other adverse condition resulting from the
September 11, 2001 terrorist attacks, is substantially likely to be a
significant factor in aggravating, contributing to, or causing cancer
or a type of cancer; (2) clinical findings from the Clinical Centers of
Excellence providing monitoring and treatment services to WTC
responders (i.e., those persons who performed rescue, recovery, clean-
up and remediation work on the WTC disaster sites) and community
members directly exposed to the dust cloud on 9/11/01; and (3) input on
the scientific criteria to be used by experts to evaluate the weight of
the medical and scientific evidence regarding such potential health
conditions.
DATES: Comments must be received by March 31, 2011.
ADDRESSES: You may submit comments, identified by docket number NIOSH-
227, by any of the following methods:
Mail: NIOSH Docket Office, Robert A. Taft Laboratories,
MS-C34, 4676 Columbia Parkway, Cincinnati, OH 45226.
Facsimile: (513) 533-8285.
E-mail: nioshdocket@cdc.gov.
All information received in response to this notice will be
available for public examination and copying at the NIOSH Docket
Office, 4676 Columbia Parkway, Cincinnati, Ohio 45226. The comment
period for NIOSH-227 will close on March 31, 2011. All comments
received will be available on the NIOSH Docket Web page at https://www.cdc.gov/niosh/docket by April 30, and comments will be available in
writing by request. NIOSH includes all comments received without change
in the docket and the electronic docket, including any personal
information provided.
FOR FURTHER INFORMATION CONTACT: Dori Reissman, M.D., NIOSH, Patriots
Plaza Suite 9200, 395 E St., SW., Washington, DC 20201, telephone (202)
245-0625 or e-mail nioshdocket@cdc.gov.
John Howard,
Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention.
[FR Doc. 2011-5157 Filed 3-7-11; 8:45 am]
BILLING CODE 4163-19-P